Oculis logo.png
Oculis updates share capital for its existing at-the-market offering program
May 17, 2024 16:30 ET | Oculis Holding AG
ZUG, May 17, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company, has issued registered ordinary shares of the...
Gennemførelse af kap
Gennemførelse af kapitalnedsættelse i Schouw & Co.
May 17, 2024 09:06 ET | Aktieselskabet Schouw & Co.
Som oplyst i selskabsmeddelelse nr. 21 blev det på Schouw & Co.s ordinære generalforsamling den 10. april 2024 besluttet at nedsætte selskabets aktiekapital fra nominelt DKK 255.000.000 til...
Reduction of share c
Reduction of share capital in Schouw & Co.
May 17, 2024 09:06 ET | Aktieselskabet Schouw & Co.
As stated in company announcement no. 21, it was decided at Schouw & Co.’s annual general meeting on 10 April 2024 to reduce the company’s share capital from nominally DKK 255,000,000 to nominally...
Nombre total de droi
Nombre total de droits de vote et d’actions composant le capital
May 17, 2024 02:00 ET | SOLUTIONS 30
Information règlementée17 mai 2024, 8h00 (Conformément à la loi et au règlement grand-ducal du 11 janvier 2008 relatifs aux obligations de transparence sur les émetteurs de valeurs mobilières) ...
Total number of voti
Total number of voting rights and shares composing the share capital
May 17, 2024 02:00 ET | SOLUTIONS 30
Regulated InformationMay 17, 2024, 8:00 am (in accordance with the law and Grand-ducal regulation of 11 January 2008 on transparency requirements for issuers) Identity of the issuer or the...
NACG Logo.png
North American Construction Group Ltd. Announces Voting Results of Annual Meeting of Shareholders
May 16, 2024 17:15 ET | North American Construction Group Ltd.
ACHESON, Alberta, May 16, 2024 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. (“NACG” or “the Company”) (TSX:NOA/NYSE:NOA) today announced the results of its Annual Meeting of...
Cellectis Logo.png
Monthly information on share capital and company voting rights
May 16, 2024 16:30 ET | Cellectis Inc.
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, May 16, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number...
Cellectis Logo.png
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
May 16, 2024 16:30 ET | Cellectis Inc.
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 16 mai 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 DateNombre total...
Nanobiotix logo.jpg
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
May 16, 2024 16:15 ET | Nanobiotix S.A.
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 16 mai 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext...
Nanobiotix logo.jpg
Voting Rights and Shares Capital of the Company
May 16, 2024 16:15 ET | Nanobiotix S.A.
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, May 16,...